Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using

Yukiyasu Okamura1, Shuji Nomoto, Mitsuro Kanda

  • 1Department of Surgery II, Graduate School and Medicine, University of Nagoya, Nagoya 466-8550, Japan.

Cancer Letters
|September 8, 2009
PubMed

Insights

Researchers identified a new suppressor gene, Leukemia Inhibitory Factor Receptor (LIFR), for hepatocellular carcinoma (HCC). LIFR gene hypermethylation was found in nearly half of HCC tumors, leading to reduced expression and suggesting its role in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options.
  • Identifying novel tumor suppressor genes is crucial for developing effective HCC treatments.

Purpose of the Study:

  • To identify novel suppressor genes in hepatocellular carcinoma (HCC) using a newly developed double-combination array.
  • To investigate the role of Leukemia Inhibitory Factor Receptor (LIFR) as a potential tumor suppressor in HCC.

Main Methods:

  • Development and application of a double-combination array for identifying suppressor genes.
  • Analysis of LIFR gene promoter hypermethylation in HCC tumor tissues.
  • Assessment of LIFR gene expression levels in tumor versus normal tissues.

Main Results:

  • The developed array successfully identified potential novel suppressor genes.
  • Promoter hypermethylation of the LIFR gene was observed in 47.9% of HCC tumor tissues analyzed.
  • Significantly reduced LIFR gene expression was detected in HCC tumor tissues compared to controls (P<0.0001).

Conclusions:

  • The study validates the efficacy of the double-combination array for novel gene discovery in cancer.
  • LIFR functions as a novel tumor suppressor gene in hepatocellular carcinoma.
  • LIFR alterations, specifically promoter hypermethylation, contribute to HCC pathogenesis.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...